Mounier-Vehier, C., Amar, J., Boivin, J.-M., Denolle, T., Fauvel, J.-P., Plu-Bureau, G., et al. (2016) Hypertension and Pregnancy. Expert Consensus Statement from the French Society of Hypertension, an Affiliate of the French Society of Cardiology. La Presse Médicale, 45, 682-699.
https://doi.org/10.1016/j.lpm.2016.05.012

has been cited by the following article:

• TITLE: Maternal-Fetal Prognosis of Eclampsia at the Second Reference Hospital in the Urban Commune of Segou in Mali

  AUTHORS: Tidiani Traoré, Cheickna Sylla, Kassoum Sidibé, Babou Traoré, Sylvain Guindo, Adama Coulibaly, Seydina A. Beye, Seydou Z. Dao, Famakan Kané, Youssouf Traoré, Ibrahima Téguété, Moustaphe Touré

  KEYWORDS: Pronostic, Maternal, Fetal, Eclampsia, Unsealed Pregnancy

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.10 No.10, October 20, 2020

  ABSTRACT: Aim: To describe the epidemiological, therapeutic and prognostic aspects of eclampsia at the second reference hospital in the urban commune of Ségou in Mali. Patient and Methods: This was a descriptive, cross-sectional, analytical, retrospective and prospective study based on a comprehensive de-engineering. It covered a 3-year period from January 1, 2010 to December 31, 2012 and involved 176 cases. Results: The incidence of eclampsia during the study period was 2.9%. Classically, it occurred in 74.4% in young primigeste, in 73.9% in the 3rd trimester of pregnancy and 26.1% of cases during postpartum. We recorded maternal complications such as retro-placental hematoma, acute kidney failure and delivery hemorrhage. The case fatality rate was 2.3% or 4 cases of maternal death. At the fetal level, there was 29.5% prematurity, 31.8% neonatal suffering, 11.4% hypotrophy, 11.9% in utero fetal death and 7.4% early neonatal death. Conclusion: The maternal-fetal prognosis remains reserved despite the progress made in the management of eclampsia in our services.